These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 11995819)
1. Imaging changes after stereotactic radiosurgery of primary and secondary malignant brain tumors. Ross DA; Sandler HM; Balter JM; Hayman JA; Archer PG; Auer DL J Neurooncol; 2002 Jan; 56(2):175-81. PubMed ID: 11995819 [TBL] [Abstract][Full Text] [Related]
2. Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: is a differential diagnosis possible? Tsuyuguchi N; Sunada I; Iwai Y; Yamanaka K; Tanaka K; Takami T; Otsuka Y; Sakamoto S; Ohata K; Goto T; Hara M J Neurosurg; 2003 May; 98(5):1056-64. PubMed ID: 12744366 [TBL] [Abstract][Full Text] [Related]
3. Semiquantitative analysis using thallium-201 SPECT for differential diagnosis between tumor recurrence and radiation necrosis after gamma knife surgery for malignant brain tumors. Matsunaga S; Shuto T; Takase H; Ohtake M; Tomura N; Tanaka T; Sonoda M Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):47-52. PubMed ID: 22541963 [TBL] [Abstract][Full Text] [Related]
4. The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery. Chao ST; Suh JH; Raja S; Lee SY; Barnett G Int J Cancer; 2001 Jun; 96(3):191-7. PubMed ID: 11410888 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of the response of metastatic brain tumors to stereotactic radiosurgery by proton magnetic resonance spectroscopy, 201TlCl single-photon emission computerized tomography, and gadolinium-enhanced magnetic resonance imaging. Kimura T; Sako K; Tanaka K; Gotoh T; Yoshida H; Aburano T; Tanaka T; Arai H; Nakada T J Neurosurg; 2004 May; 100(5):835-41. PubMed ID: 15137602 [TBL] [Abstract][Full Text] [Related]
6. Integration of the metabolic data of positron emission tomography in the dosimetry planning of radiosurgery with the gamma knife: early experience with brain tumors. Technical note. Levivier M; Wikier D; Goldman S; David P; Metens T; Massager N; Gerosa M; Devriendt D; Desmedt F; Simon S; Van Houtte P; Brotchi J J Neurosurg; 2000 Dec; 93 Suppl 3():233-8. PubMed ID: 11143256 [TBL] [Abstract][Full Text] [Related]
7. Differentiation between recurrent brain tumour and post-radiation necrosis: the value of 201Tl SPET versus 18F-FDG PET using a dual-headed coincidence camera--a pilot study. Stokkel M; Stevens H; Taphoorn M; Van Rijk P Nucl Med Commun; 1999 May; 20(5):411-7. PubMed ID: 10404525 [TBL] [Abstract][Full Text] [Related]
8. Brain metastases after stereotactic radiosurgery using the Leksell gamma knife: can FDG PET help to differentiate radionecrosis from tumour progression? Belohlávek O; Simonová G; Kantorová I; Novotný J; Liscák R Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):96-100. PubMed ID: 12483415 [TBL] [Abstract][Full Text] [Related]
9. Comparison of effects of 18F-FDG PET-CT and MRI in identifying and grading gliomas. Song PJ; Lu QY; Li MY; Li X; Shen F J Biol Regul Homeost Agents; 2016; 30(3):833-838. PubMed ID: 27655507 [TBL] [Abstract][Full Text] [Related]
10. Usefulness of semiquantitative FDG-PET in the prediction of brain tumor treatment response to gamma knife radiosurgery. Lee JK; Liu RS; Shiang HR; Pan DH J Comput Assist Tomogr; 2003; 27(4):525-9. PubMed ID: 12886136 [TBL] [Abstract][Full Text] [Related]
11. Stereotactic radiosurgery in patients with multiple brain metastases. Chang SD; Lee E; Sakamoto GT; Brown NP; Adler JR Neurosurg Focus; 2000 Aug; 9(2):e3. PubMed ID: 16836289 [TBL] [Abstract][Full Text] [Related]
12. [Metabolic imaging to follow stereotactic radiation of gliomas -- the role of 1H MR spectroscopy in comparison to FDG-PET and IMT-SPECT]. Lichy MP; Henze M; Plathow C; Bachert P; Kauczor HU; Schlemmer HP Rofo; 2004 Aug; 176(8):1114-21. PubMed ID: 15346287 [TBL] [Abstract][Full Text] [Related]
13. Hyperacute changes in glucose metabolism of brain tumors after stereotactic radiosurgery: a PET study. Maruyama I; Sadato N; Waki A; Tsuchida T; Yoshida M; Fujibayashi Y; Ishii Y; Kubota T; Yonekura Y J Nucl Med; 1999 Jul; 40(7):1085-90. PubMed ID: 10405124 [TBL] [Abstract][Full Text] [Related]
14. Impact of the radiosurgery prescription dose on the local control of small (2 cm or smaller) brain metastases. Mohammadi AM; Schroeder JL; Angelov L; Chao ST; Murphy ES; Yu JS; Neyman G; Jia X; Suh JH; Barnett GH; Vogelbaum MA J Neurosurg; 2017 Mar; 126(3):735-743. PubMed ID: 27231978 [TBL] [Abstract][Full Text] [Related]
15. Recurrent tumor vs radiation effects after gamma knife radiosurgery of intracerebral metastases: diagnosis with PET-FDG. Mogard J; Kihlström L; Ericson K; Karlsson B; Guo WY; Stone-Elander S J Comput Assist Tomogr; 1994; 18(2):177-81. PubMed ID: 8126264 [TBL] [Abstract][Full Text] [Related]
16. Transient enlargement of contrast uptake on MRI after linear accelerator (linac) stereotactic radiosurgery for brain metastases. Huber PE; Hawighorst H; Fuss M; van Kaick G; Wannenmacher MF; Debus J Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1339-49. PubMed ID: 11286842 [TBL] [Abstract][Full Text] [Related]
17. A surgical strategy using a fusion image constructed from 11C-methionine PET, 18F-FDG-PET and MRI for glioma with no or minimum contrast enhancement. Ideguchi M; Nishizaki T; Ikeda N; Okamura T; Tanaka Y; Fujii N; Ohno M; Shimabukuro T; Kimura T; Ikeda E; Suga K J Neurooncol; 2018 Jul; 138(3):537-548. PubMed ID: 29516344 [TBL] [Abstract][Full Text] [Related]
18. Prediction of pathology and survival by FDG PET in gliomas. Padma MV; Said S; Jacobs M; Hwang DR; Dunigan K; Satter M; Christian B; Ruppert J; Bernstein T; Kraus G; Mantil JC J Neurooncol; 2003 Sep; 64(3):227-37. PubMed ID: 14558598 [TBL] [Abstract][Full Text] [Related]
20. Use of stereotactic PET images in dosimetry planning of radiosurgery for brain tumors: clinical experience and proposed classification. Levivier M; Massager N; Wikler D; Lorenzoni J; Ruiz S; Devriendt D; David P; Desmedt F; Simon S; Van Houtte P; Brotchi J; Goldman S J Nucl Med; 2004 Jul; 45(7):1146-54. PubMed ID: 15235060 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]